Nautilus Biotechnology, Inc. (NAUT) Market Cap & Valuation Ratios
Nautilus Biotechnology, Inc. (NAUT) has a market cap of $412.3M, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
NAUTNautilus Biotechnology, Inc.Follow NAUT — free
—
Price chart with a free account
- Market cap
- 412.3M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 27 Oct, in 3 days
Peers
scientific & technical instruments · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| NAUT | 0.4 | — | — | — | -12.6% | — | — | -43% |
| NOVT | 5.3 | 89.7 | 4.7 | 31.4 | 2.1% | +8% | 9% | 6% |
| VNT | 4.6 | 14.2 | 2.0 | 10.0 | 8.3% | +0.9% | 19% | 16% |
| BMI | 4.3 | 34.9 | 4.8 | 20.9 | 3.3% | -2% | 19% | 23% |
| ITRI | 3.8 | 14.7 | 2.0 | 12.7 | 10.0% | -6% | 13% | 13% |
| ALMR | 2.1 | — | — | — | — | — | -46% | — |
| FEIM | 0.7 | — | 9.1 | 186.8 | -0.0% | +6% | 3% | 3% |
| MLAB | 0.7 | — | 3.3 | 18.3 | 7.3% | +3% | 9% | 4% |
| VPG | 0.7 | — | 2.0 | 23.6 | -1.1% | +11% | 3% | 2% |
| SENS | 0.4 | — | 6.4 | — | — | +91% | -223% | -108% |
| OPTX | 0.3 | — | 8.8 | 235.5 | -0.2% | +1% | -5% | -7% |
| Median of these 10 | 24.8 | 4.7 | 22.2 | 2.7% | +3% | 6% | 4% |
.
Growth vs. price
each dot a company · hover or tap for valuesNAUT and ALMR and FEIM and MLAB and VPG and SENS and OPTX have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Nautilus Biotechnology, Inc. — questions
- What is Nautilus Biotechnology, Inc.'s market cap?
- $412.3M.
Every figure on this page comes from Nautilus Biotechnology, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.